American Century Companies Inc Catalyst Pharmaceuticals, Inc. Transaction History
American Century Companies Inc
- $176 Billion
- Q2 2025
A detailed history of American Century Companies Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,757,988 shares of CPRX stock, worth $36.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,757,988
Previous 526,569
233.86%
Holding current value
$36.2 Million
Previous $12.8 Million
198.75%
% of portfolio
0.02%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding CPRX
# of Institutions
385Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$180 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$113 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.9 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$65.5 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.12B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...